Sherwin Stephen A's Form 4 filing
Neurocrine Biosciences Inc (NBIX) · filed Jun 9, 2026
- Accession no.
- 0001079462-26-000006
- Filed
- Jun 9, 2026
- Trade date
- Jun 5, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 7 non-derivative transactions and 2 derivative transactions. Open-market sales total $4.13M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sherwin Stephen ACIK 0001079462 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | Common Stock | MOption exerciseAcquired | +15,000 | $53.64 | +$804,600 | 30,860 | Direct | |
| Jun 5, 2026 | Common Stock | MOption exerciseAcquired | +10,000 | $79.79 | +$797,900 | 40,860 | Direct | |
| Jun 5, 2026 | Common Stock | SSaleDisposed | −7,883 | $163.81 | −$1,291,314.23 | 32,977 | Direct | |
| Jun 5, 2026 | Common Stock | SSaleDisposed | −2,549 | $164.44 | −$419,157.56 | 30,428 | Direct | |
| Jun 5, 2026 | Common Stock | SSaleDisposed | −6,896 | $165.79 | −$1,143,287.84 | 23,532 | Direct | |
| Jun 5, 2026 | Common Stock | SSaleDisposed | −5,829 | $166.56 | −$970,878.24 | 17,703 | Direct | |
| Jun 5, 2026 | Common Stock | SSaleDisposed | −1,843 | $167.31 | −$308,352.33 | 15,860 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | Common Stock | MOption exerciseDisposed | −15,000 | $0.00 | $0 | 0 | Direct | |
| Jun 5, 2026 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.